Live Breaking News & Updates on Accelerate diagnostics

Stay informed with the latest breaking news from Accelerate diagnostics on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Accelerate diagnostics and stay connected to the pulse of your community

Accelerate Diagnostics, Inc. (NASDAQ:AXDX) CEO Jack Phillips Sells 26,545 Shares of Stock

Accelerate Diagnostics, Inc. (NASDAQ:AXDX – Get Free Report) CEO Jack Phillips sold 26,545 shares of the business’s stock in a transaction on Friday, April 12th. The shares were sold at an average price of $0.86, for a total value of $22,828.70. Following the completion of the sale, the chief executive officer now owns 129,726 shares […]

United-states , Jack-phillips , Craig-hallum , William-blair , Nasdaq , Vanguard-group-inc , Baird-financial-group-inc , Geode-capital-management , Griffin-asset-management-inc , Diagnostics-inc , Accelerate-diagnostics , Get-free-report

Accelerate Diagnostics : Announces 510(k) Submission of the Accelerate Arc™ System to the FDA -April 09, 2024 at 06:09 pm EDT

Accelerate Diagnostics Announces 510 Submission of the Accelerate Arc™ System to the FDA

Apr 09, 2024

Enabling rapid, automated microbial identification...

Jack-phillips , Nasdaq , Diagnostics-inc , Accelerate-diagnostics-announces , Accelerate-arc , Accelerate-diagnostics , Accelerate-pheno , Accelerate-phenotest , All-rights , Markets ,

Accelerate Diagnostics, Inc. (NASDAQ:AXDX) CEO Sells $13,980.56 in Stock

Accelerate Diagnostics, Inc. (NASDAQ:AXDX – Get Free Report) CEO Jack Phillips sold 15,887 shares of the stock in a transaction that occurred on Thursday, April 4th. The shares were sold at an average price of $0.88, for a total transaction of $13,980.56. Following the transaction, the chief executive officer now directly owns 96,343 shares of […]

United-states , Jack-phillips , William-blair , Craig-hallum , Geode-capital-management , Vanguard-group-inc , Diagnostics-company-profile , Diagnostics-inc , Griffin-asset-management-inc , Baird-financial-group-inc , Nasdaq , Accelerate-diagnostics

Accelerate Diagnostics, Inc. (NASDAQ:AXDX) CEO Jack Phillips Sells 15,887 Shares

Accelerate Diagnostics, Inc. (NASDAQ:AXDX – Get Free Report) CEO Jack Phillips sold 15,887 shares of the stock in a transaction dated Thursday, April 4th. The stock was sold at an average price of $0.88, for a total transaction of $13,980.56. Following the transaction, the chief executive officer now owns 96,343 shares of the company’s stock, […]

United-states , Craig-hallum , Jack-phillips , William-blair , Griffin-asset-management-inc , Sonora-investment-management-group , Diagnostics-inc , Nasdaq , Wealth-advisors-inc , Geode-capital-management , Tejara-capital-ltd , Accelerate-diagnostics

Equities Research Analysts' New Coverage for April 4th (ABIO, ACOR, AEMD, AGRX, AHPI, AIRI, ALUR, ATHX, AXDX, AZTA)

Equities Research Analysts’ new coverage for Thursday, April 4th: StockNews.com started coverage on shares of ARCA biopharma (NASDAQ:ABIO). The firm issued a sell rating on the stock. StockNews.com began coverage on shares of Acorda Therapeutics (NASDAQ:ACOR). The firm issued a buy rating on the stock. StockNews.com assumed coverage on shares of Aethlon Medical (NASDAQ:AEMD). They […]

United-states , Phoenix , Arizona , China , America , Piper-sandler , Sanfordc-bernstein , Robertw-baird , Raymond-james , Jpmorgan-chase-co , Cantor-fitzgerald , Flanigan-enterprises

Accelerate Diagnostics, Inc. (NASDAQ:AXDX) Q4 2023 Earnings Call Transcript

Accelerate Diagnostics, Inc. misses on earnings expectations. Reported EPS is $-0.89 EPS, expectations were $-0.62. Accelerate Diagnostics, Inc.

Idaho , United-states , Barcelona , Comunidad-autonoma-de-cataluna , Spain , Jack-phillips , William-blair , Alex-nowak , Dustin-scaringe , Laura-pierson , Andrew-brackmann , Nasdaq

Accelerate Diagnostics (NASDAQ:AXDX) PT Lowered to $1.00

Accelerate Diagnostics (NASDAQ:AXDX – Get Free Report) had its price target decreased by investment analysts at Craig Hallum from $2.00 to $1.00 in a research report issued to clients and investors on Monday, Benzinga reports. The firm currently has a “hold” rating on the medical research company’s stock. Craig Hallum’s price objective suggests a potential […]

United-states , Craig-hallum , Vanguard-group-inc , Griffin-asset-management-inc , Baird-financial-group-inc , Nasdaq , Diagnostics-inc , Geode-capital-management , Accelerate-diagnostics , Get-free-report , Financial-group , Street-corp

AXDX Stock Earnings: Accelerate Diagnostics Misses EPS, Misses Revenue for Q4 2023

AXDX Stock Earnings: Accelerate Diagnostics Misses EPS, Misses Revenue for Q4 2023
biztoc.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biztoc.com Daily Mail and Mail on Sunday newspapers.

Market-news , Stock-advice , Accelerate-diagnostics , Accelerate-diagnostics-misses , Misses-revenue ,

StockNews.com Initiates Coverage on Accelerate Diagnostics (NASDAQ:AXDX)

Analysts at StockNews.com assumed coverage on shares of Accelerate Diagnostics (NASDAQ:AXDX – Get Free Report) in a report issued on Wednesday. The firm set a “hold” rating on the medical research company’s stock. Accelerate Diagnostics Trading Down 2.0 % Accelerate Diagnostics stock opened at $0.99 on Wednesday. The firm’s 50 day simple moving average is […]

United-states , Tejara-capital-ltd , Morgan-stanley , Diagnostics-inc , Baird-financial-group-inc , Vanguard-group-inc , Accelerate-diagnostics , Get-free-report , Diagnostics-trading-down , Capital-ltd , Financial-group

Earnings Scheduled For March 28, 2024 - Ascent Industries (NASDAQ:ACNT), Achieve Life Sciences (NASDAQ:ACHV)

Companies Reporting Before The Bell • Universal Stainless (NASDAQ:USAP) is expected to report quarterly earnings at $0.32 per share on revenue of $78.65 million.

United-states , Jiayin , Heilongjiang , China , American , Inmune-bio , Cnfinance-hldgs , American-oncology-network , Pineapple-energy , Cheche-group , Naas-technology , Companies-reporting